Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | ATM | Q13315 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | RARB | P10826 | 1/20 | 0.39 |
| ▸ | PDE5A | O76074 | 3/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | BCL2 | P10415 | 2/20 | 0.37 |
| ▸ | BCHE | P06276 | 2/20 | 0.37 |
| ▸ | BECN1 | Q14457 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15901983 | 0.77 | TDP1 (0.58) | TDP1RARB | |
| SCHEMBL15902546 | 0.77 | TDP1 (0.58) | TDP1RARB | |
| SCHEMBL15901747 | 0.77 | TDP1 (0.58) | TDP1RARB | |
| SCHEMBL246612 | 0.74 | TDP1 (0.71) | TDP1RARB | |
| SCHEMBL3031699 | 0.74 | TDP1 (0.71) | TDP1RARB | |
| SCHEMBL21829 | 0.74 | TDP1 (0.71) | TDP1RARB | |
| SCHEMBL13048767 | 0.74 | TDP1 (0.71) | TDP1RARB | |
| SCHEMBL1401943 | 0.74 | TDP1 (0.71) | TDP1RARB | |
| SCHEMBL20606290 | 0.74 | TDP1 (0.71) | TDP1RARB | |
| SCHEMBL4334899 | 0.74 | TDP1 (0.71) | TDP1RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097639-B2 | Light sensitive PDMS for complex pattern formation | PEKING UNIVERSITY (CN) | 2012-01-17 | — | — | US | disclosed |
| US-20110196111-A1 | LIGHT SENSITIVE PDMS FOR COMPLEX PATTERN FORMATION | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110196111-A1 | LIGHT SENSITIVE PDMS FOR COMPLEX PATTERN FORMATION | SELE, EPCAM, PIEZO1 | NR3C2 3266/4885MEN1 1758/4885KMT2A 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.